- drug
produced by
Movetis was
Prucalopride (known by the
brand name "Resolor"),
indicated for
cases of
chronic constipation.
Movetis was
founded by Dirk...
- of the most
acquisitive in the industry. In 2010 the
company acquired Movetis, a
Belgian company focusing on
gastrointestinal products for $565 million...
- (2004–2016)
Meyer Brothers (1852–1981)
Miles Laboratories (1884–1995)
Movetis (2006–2010)
Mylan (1961–2019)
Nederlandsche Cocaïnefabriek (1900–1962)...
- (Acq 2005) New
River Pharmaceuticals Inc (Acq 2007)
Jerini (Acq 2008)
Movetis (Acq 2012)
Advanced BioHealing (Acq 2011)
FerroKin BioSciences (Acq 2012)...
-
sciences companies including Flamel, Cerep, Genset, Actelion, Preglem,
Movetis, Ascendis, Obseva,
Auris and Nucana. The
firms have a
collegial relationship...
-
Gastrointestinal Discovery. In 2007, he
founded a new
pharmaceutical company,
Movetis,
together with Remi Van den Broeck, Staf Van Reet and Dirk Reyn. 1997,...
-
venturing activities in
Europe for
Johnson & Johnson. In 2007 he
founded Movetis together with Remi Van den Broeck, Dirk Reyn and Jan Schuurkes. Staf Van...
- NASDAQ) on its all-cash
voluntary takeover bid for the
outstanding shares of
Movetis, a
Belgian biotech company listed on
Euronext Brussels.
Along with Slaughter...
